Article ID Journal Published Year Pages File Type
8231989 International Journal of Radiation Oncology*Biology*Physics 2010 7 Pages PDF
Abstract
Triple therapy with RCT and cetuximab seems to be feasible, with no unexpected toxicity. Early response assessment (TRG), however, suggests subadditive interaction. A longer follow-up (and finally randomized trials) is needed to draw any firm conclusions with respect to local and distant failure rates.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , , , , ,